Delivery Order SPE2DB22D1041-SPE2DB25FUBS2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Valtoco 20 mg nasal sprays, with a ceiling value of $5,854.54. The order is set to be completed by September 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside provisions and represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a $1,128.54 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of August 20, 2025. This firm fixed-price contract, which was competitively awarded without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at the awardee's...
- The Defense Logistics Agency awarded a $3,210.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 24, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,106.66 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of September 15, 2025. This competitive award (no set-aside used) represents a firm fixed-price delivery order executed on September 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a naloxone nasal spray used for emergency treatment of opioid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,126.10. The order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 3, 2025. This firm fixed-price contract, awarded on September 2, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Valtoco is a naloxone nasal spray formulation used for...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,126.10 to AmerisourceBergen Drug Corp for the supply of Valtoco 5 mg nasal sprays. This firm fixed-price, non-set-aside delivery order was awarded on June 12, 2025, with an ultimate completion date of June 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,385.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 15, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order contains no set-aside...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 15 mg nasal spray with a ceiling value of $1,128.54. This is a firm fixed price, non-set-aside delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBS2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valtoco 5 mg nasal spray, with a ceiling value of $2,252.20 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a naloxone nasal spray product used for emergency treatment of opioid overdose. This delivery order reflects AmerisourceBergen's critical role as a pharmaceutical prime vendor for the Defense Logistics Agency's medical supply chain, providing essential medications and medical supplies to support military and veteran healthcare systems. As a major distributor of both brand-name and generic pharmaceuticals, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition and maintains an extensive portfolio of therapeutic products delivered to defense and civilian government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/3/25 |